Avenue Therapeutics Inc (ATXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,132 | 8,745 | 2,671 | 11,782 | 197 |
| Marketable Securities | N/A | N/A | N/A | 10,000 | N/A |
| Other current assets | 0 | 0 | 1,702 | 0 | 0 |
| TOTAL | $3,245 | $8,915 | $4,525 | $22,170 | $197 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $3,245 | $8,915 | $4,525 | $22,170 | $197 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 886 | 2,101 | 4,669 | 2,737 | 563 |
| Accrued Expenses | N/A | 14 | 487 | 53 | 1,694 |
| Other current liabilities | N/A | N/A | N/A | N/A | 314 |
| TOTAL | $886 | $2,115 | $5,156 | $2,790 | $6,419 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 2,026 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $2,026 |
| Total Liabilities | $886 | $2,115 | $5,156 | $2,790 | $8,445 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 15 | 15 | 15 | 9 | N/A |
| Common Shares | 2 | 2 | 1 | 1,104 | 50 |
| Retained earnings | -73,268 | -68,117 | -42,209 | -20,661 | -8,403 |
| TOTAL | $2,359 | $6,800 | $-631 | $19,380 | $-8,248 |
| Total Liabilities And Equity | $3,245 | $8,915 | $4,525 | $22,170 | $197 |